We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
(+14%)
Cap. Flow
+$2.65B
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$255M |
| 2 |
Apple
AAPL
|
+$173M |
| 3 |
Microsoft
MSFT
|
+$166M |
| 4 |
JPMorgan Chase
JPM
|
+$134M |
| 5 |
Amazon
AMZN
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$74.8M |
| 2 |
Accenture
ACN
|
+$70.7M |
| 3 |
Elevance Health
ELV
|
+$69.2M |
| 4 |
HES
Hess
HES
|
+$59.9M |
| 5 |
Motorola Solutions
MSI
|
+$53.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.07% |
| 2 | Financials | 13.98% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Communication Services | 10.11% |
| 5 | Healthcare | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
876
DELISTED
Juniper Networks
JNPR
| – | – |
-245,213
| Closed | -$9.79M |
|
877
CarMax
KMX
$8.27B
| – | – |
-5,791
| Closed | -$389K |
|
878
Kaspi.kz JSC
KSPI
$16.3B
| – | – |
-8,385
| Closed | -$712K |
|
879
Kontoor Brands
KTB
$4.62B
| – | – |
-6,879
| Closed | -$454K |
|
880
LKQ Corp
LKQ
$6.58B
| – | – |
-183,095
| Closed | -$6.78M |
|
881
Lattice Semiconductor
LSCC
$17.6B
| – | – |
-9,569
| Closed | -$469K |
|
882
Matsons
MATX
$6.37B
| – | – |
-4,133
| Closed | -$460K |
|
883
Moderna
MRNA
$21.5B
| – | – |
-12,398
| Closed | -$342K |
|
884
Old National Bancorp
ONB
$10.1B
| – | – |
-24,198
| Closed | -$516K |
|
885
Prosperity Bancshares
PB
$8.77B
| – | – |
-5,636
| Closed | -$396K |
|
886
Piper Sandler
PIPR
$5.14B
| – | – |
-7,284
| Closed | -$506K |
|
887
PrimeEnergy Resources
PNRG
$303M
| – | – |
-1,917
| Closed | -$281K |
|
888
Ralph Lauren
RL
$22.2B
| – | – |
-1,875
| Closed | -$514K |
|
889
RLI Corp
RLI
$5.68B
| – | – |
-6,781
| Closed | -$490K |
|
|
SEZL
890
Sezzle
SEZL
$5.17B
| – | – |
-4,065
| Closed | -$729K |
|
891
Steven Madden
SHOO
$3.12B
| – | – |
-19,187
| Closed | -$460K |
|
892
Scorpio Tankers
STNG
$3.96B
| – | – |
-11,245
| Closed | -$440K |
|
893
Stanley Black & Decker
SWK
$14.2B
| – | – |
-5,749
| Closed | -$389K |
|
894
Skyworks Solutions
SWKS
$9.06B
| – | – |
-5,909
| Closed | -$440K |
|
895
Bio-Techne
TECH
$11.2B
| – | – |
-5,739
| Closed | -$295K |
|
896
Texas Roadhouse
TXRH
$12.7B
| – | – |
-2,428
| Closed | -$455K |
|
897
Vital Farms
VITL
$558M
| – | – |
-13,778
| Closed | -$531K |
|
898
Viatris
VTRS
$20.1B
| – | – |
-44,496
| Closed | -$397K |
|
899
West Fraser Timber
WFG
$5.18B
| – | – |
-37,803
| Closed | -$2.77M |
|
900
WIX.com
WIX
$2.15B
| – | – |
-3,351
| Closed | -$531K |
|
Similar funds
QCM
NAMI
Aviva's Q3 2025 Portfolio in Review
As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.
- Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
- Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
- Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
- Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
- Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
- Aviva opened 47 new positions and closed 58 in Q3 2025.
- Aviva's portfolio value rose 14% quarter-over-quarter to $55B.
Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.